Agenus Inc (AGEN.OQ)

AGEN.OQ on NASDAQ Stock Exchange Capital Market

2.96USD
15 Sep 2014
Price Change (% chg)

$-0.16 (-5.13%)
Prev Close
$3.12
Open
$3.12
Day's High
$3.12
Day's Low
$2.94
Volume
61,668
Avg. Vol
242,154
52-wk High
$5.25
52-wk Low
$2.27

AGEN.OQ

Chart for AGEN.OQ

About

Agenus Inc., including its subsidiaries, (Agenus) is a biotechnology company focused on the development and commercialization of technologies to treat cancers and infectious diseases. The Company's core technology portfolio consists of its Saponin Platform (based on its saponin adjuvant based technologies) and its Heat Shock... (more)

Overall

Beta: 1.77
Market Cap (Mil.): $195.56
Shares Outstanding (Mil.): 62.68
Dividend: --
Yield (%): --

Financials

  AGEN.OQ Industry Sector
P/E (TTM): -- 148.78 33.52
EPS (TTM): -0.56 -- --
ROI: -44.87 -3.25 17.33
ROE: -107.50 -7.86 18.19
Search Stocks

UPDATE 2-GSK seeks approval for world's first malaria vaccine

* Mosquito-borne malaria kills over 600,000 people a year

24 Jul 2014

Agenus brain cancer vaccine doubles survival rate in study

- Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.

01 Jul 2014

UPDATE 1-Agenus brain cancer vaccine doubles survival rate in study

July 1 - Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.

01 Jul 2014

Agenus brain cancer vaccine nearly doubles survival rate in study

July 1 - Agenus Inc said its experimental cancer vaccine helped brain tumor patients live nearly twice as long compared with those who received standard of care treatment.

01 Jul 2014

US STOCKS-S&P 500, Dow end up after late rebound; Apple, Pfizer lift

(Updates close with jump in Agenus; adds Gogo's shares down after the bell)

28 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks